Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_assertion type Assertion NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_head.
- NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_assertion description "[We compared clinicopathologic factors, including age, sex, WBC count, cerebrospinal fluid (CSF) involvement, immunophenotype, and blast proliferation rate between B-ALL with RUNX1 amplification (10 cases) and B-ALL with ETV6-RUNX1 translocation (67 cases) in childhood B-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_provenance.
- NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_assertion evidence source_evidence_literature NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_provenance.
- NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_assertion SIO_000772 26185316 NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_provenance.
- NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_assertion wasDerivedFrom befree-2016 NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_provenance.
- NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_assertion wasGeneratedBy ECO_0000203 NP1290339.RAkvrx9cQeaEx3zOFXcIolCj7FUY7S5RH0q4FXbgA-y30130_provenance.